Nova Scotia Health Employees' Pension Plan v. Comerica Incorporated

CourtCourt of Appeals for the Ninth Circuit
DecidedFebruary 6, 2026
Docket24-7673
StatusUnpublished

This text of Nova Scotia Health Employees' Pension Plan v. Comerica Incorporated (Nova Scotia Health Employees' Pension Plan v. Comerica Incorporated) is published on Counsel Stack Legal Research, covering Court of Appeals for the Ninth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Nova Scotia Health Employees' Pension Plan v. Comerica Incorporated, (9th Cir. 2026).

Opinion

NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS FEB 6 2026 MOLLY C. DWYER, CLERK U.S. COURT OF APPEALS FOR THE NINTH CIRCUIT

NOVA SCOTIA HEALTH EMPLOYEES' No. 24-7673 PENSION PLAN, Lead Plaintiff, D.C. No. 2:23-cv-06843-SB-JPR Plaintiff - Appellant,

and MEMORANDUM*

DAVID RAMOS,

Plaintiff,

v.

COMERICA INCORPORATED; CURTIS C. FARMER; JAMES J. HERZOG,

Defendants - Appellees.

Appeal from the United States District Court for the Central District of California Stanley Blumenfeld, Jr., District Judge, Presiding

Submitted February 4, 2026** Pasadena, California

Before: LEE, KOH, and DE ALBA, Circuit Judges.

* This disposition is not appropriate for publication and is not precedent except as provided by Ninth Circuit Rule 36-3. ** The panel unanimously concludes this case is suitable for decision without oral argument. See Fed. R. App. P. 34(a)(2). Appellants Nova Scotia Health Employees’ Pension Plan (“NSHEPP”) and

David Ramos brought this putative securities class action under Sections 10(b) and

20(a) of the Securities Exchange Act and Rule 10b-5 against Appellees Comerica

Incorporated (“Comerica”); Comerica’s CEO, Curtis C. Farmer (“Farmer”); and

Comerica’s CFO, James J. Herzog. On appeal, Appellants argue that the district

court erred in dismissing the Third Amended Complaint (“TAC”) for failure to

state a claim, denying leave to amend, and denying reconsideration. We have

jurisdiction under 28 U.S.C. § 1291, and we affirm.

We review the district court’s dismissal of a complaint for failure to state a

claim de novo. “On review, we accept the plaintiffs’ allegations as true and

construe them in the light most favorable to plaintiffs.” In re Gilead Scis. Sec.

Litig., 536 F.3d 1049, 1055 (9th Cir. 2008) (quoting Gompper v. VISX, Inc., 298

F.3d 893, 895 (9th Cir. 2002)). “The court need not, however, accept as true

allegations that . . . . are merely conclusory, unwarranted deductions of fact, or

unreasonable inferences.” Sprewell v. Golden State Warriors, 266 F.3d 979, 988

(9th Cir. 2001) (citation omitted), amended on other grounds, 275 F.3d 1187 (9th

Cir. 2001). “We review the denial of leave to amend for an abuse of discretion, but

we review the question of futility of amendment de novo.” B&G Foods N. Am.,

Inc. v. Embry, 29 F.4th 527, 534 (9th Cir. 2022) (quoting United States v. United

Healthcare Ins. Co., 848 F.3d 1161, 1172 (9th Cir. 2016)). We review denial of a

2 motion for reconsideration for abuse of discretion. Phelps v. Alameida, 569 F.3d

1120, 1131 (9th Cir. 2009).

1. NSHEPP alleged that Comerica, as Financial Agent of the Department

of Treasury’s Bureau of Fiscal Service’s (“Fiscal Service”) Direct Express

program, violated the governing regulations and contractual requirements of the

Direct Express program, and that Comerica and its executives committed securities

fraud by hiding the violations. The district court correctly dismissed the TAC for

failure to adequately allege that Appellees’ fraud caused Appellants’ loss.

Loss causation, “i.e., a causal connection between the material

misrepresentation and the loss” is a basic element of a Section 10(b) claim. Dura

Pharms., Inc. v. Broudo, 544 U.S. 336, 342 (2005).1 “So long as the complaint

alleges facts that, if taken as true, plausibly establish loss causation, a Rule

12(b)(6) dismissal is inappropriate.” Gilead, 536 F.3d at 1057.

“Loss causation is established if the market learns of a defendant’s

fraudulent act or practice, the market reacts to the fraudulent act or practice, and a

plaintiff suffers a loss as a result of the market’s reaction.” In re Oracle Corp. Sec.

Litig., 627 F.3d 376, 392 (9th Cir. 2010). “The most common way for plaintiffs to

1 NSHEPP’s Section 20(a) claim depends on its Section 10(b) claim. See Zucco Partners, LLC v. Digimarc Corp., 552 F.3d 981, 990 (9th Cir. 2009) (“Section 20(a) claims may be dismissed summarily . . . if a plaintiff fails to adequately plead a primary violation of section 10(b).”).

3 prove that the truth became known is to identify one or more corrective

disclosures. A corrective disclosure occurs when information correcting the

misstatement or omission that is the basis for the action is disseminated to the

market.” In re BofI Holding, Inc. Sec. Litig., 977 F.3d 781, 790 (9th Cir. 2020)

(internal quotes and citations omitted).

NSHEPP alleged that three corrective disclosures revealed risks regarding

Comerica’s probability of being renewed as Financial Agent for the Direct Express

Program.2 The district court correctly concluded that none of these alleged

disclosures established loss causation.

A. First Disclosure and Alleged Re-concealment

The first alleged disclosure is a May 29, 2023 American Banker article (“AB

Article”) that NSHEPP alleges revealed compliance issues with two third-party

vendors. The AB Article revealed information from nonpublic documents

indicating that Comerica’s two third-party vendors, i2c Inc. (“i2c”) and Conduent

Business Services (“Conduent”), had failed to follow regulatory and contractual

requirements for processing Direct Express cardholder disputes. Among other

violations in processing cardholding disputes, the AB Article revealed that i2c had

2 Before the district court, NSHEPP also argued that various analyst reports correlated with “small price drops” constituted corrective disclosures. The district court concluded that none of the reports constituted corrective disclosures because these reports largely pre-dated the AB Article and were unrelated to the Direct Express program. None of these reports are a basis for NSHEPP’s appeal.

4 processed Direct Express cardholder disputes in Pakistan, which violated the

FAA’s requirement that all Direct Express services be provided in the United

States by United States citizens or lawful permanent residents. The AB Article also

summarized already public information showing that Comerica had long been

subject to various complaints and investigations regarding its compliance

deficiencies and dispute processing procedures, including a congressional

investigation in 2018, a class action lawsuit in 2019, and audits by the Treasury’s

Office of Inspector General (“OIG”) with reports published in 2014, 2017, and

2020.

Because Comerica’s stock price decline following the AB Article was

modest, typical, and quickly reversed, NSHEPP has not plausibly alleged that the

fraud disclosed by the AB Article caused Comerica’s drop in stock price. Where

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. United States Gypsum Co.
333 U.S. 364 (Supreme Court, 1948)
Dura Pharmaceuticals, Inc. v. Broudo
544 U.S. 336 (Supreme Court, 2005)
Cutera Securities Litigation v. Conners
610 F.3d 1103 (Ninth Circuit, 2010)
In Re Oracle Corp. Securities Litigation
627 F.3d 376 (Ninth Circuit, 2010)
Jacqlyn Smith v. Clark County School District
727 F.3d 950 (Ninth Circuit, 2013)
Phelps v. Alameida
569 F.3d 1120 (Ninth Circuit, 2009)
Zucco Partners, LLC v. Digimarc Corp.
552 F.3d 981 (Ninth Circuit, 2009)
Metzler Investment GMBH v. Corinthian Colleges, Inc.
540 F.3d 1049 (Ninth Circuit, 2008)
In Re Gilead Sciences Securities Litigation
536 F.3d 1049 (Ninth Circuit, 2008)
Leadsinger, Inc. v. BMG Music Publishing
512 F.3d 522 (Ninth Circuit, 2008)
In Re Verifone Securities Litigation
784 F. Supp. 1471 (N.D. California, 1992)
Karim Khoja v. Orexigen Therapeutics, Inc.
899 F.3d 988 (Ninth Circuit, 2018)
Gregory Wochos v. Tesla, Inc.
985 F.3d 1180 (Ninth Circuit, 2021)
B&G Foods North America, Inc. v. Kim Embry
29 F.4th 527 (Ninth Circuit, 2022)
Sprewell v. Golden State Warriors
266 F.3d 979 (Ninth Circuit, 2001)
Sprewell v. Golden State Warriors
275 F.3d 1187 (Ninth Circuit, 2001)
Gompper v. Visx, Inc.
298 F.3d 893 (Ninth Circuit, 2002)
United States v. United Healthcare Insurance Co.
848 F.3d 1161 (Ninth Circuit, 2016)

Cite This Page — Counsel Stack

Bluebook (online)
Nova Scotia Health Employees' Pension Plan v. Comerica Incorporated, Counsel Stack Legal Research, https://law.counselstack.com/opinion/nova-scotia-health-employees-pension-plan-v-comerica-incorporated-ca9-2026.